Pubic Symphysis Dysfunction (Non-Pregnancy)
Investigational use for non-pregnancy pubic symphysis dysfunction, including osteitis pubis; no clinical study of leech therapy was identified.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for pubic symphysis dysfunction. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational; no clinical study or case report of leech therapy for this condition was identified.
- What evidence exists?
- Tier C (investigational). We did not find any clinical study or case report of leech therapy for pubic symphysis dysfunction, so its benefit is unknown. Non-pregnancy pubic symphysis dysfunction (osteitis pubis, adductor enthesopathy) is most common in athletes. Evidence-based management includes rest, NSAIDs, progressive return-to-sport protocols, adductor and core strengthening, and image-guided corticosteroid injection for refractory cases. Pregnancy-related symphysis pubis dysfunction is a separate clinical entity managed by physiotherapy, pelvic support belt, and obstetric care, and is a relative contraindication for leech therapy.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness over the pubic region for 5 to 14 days
- Local skin infection or Aeromonas infection (region near urogenital structures)
- Allergic reaction to leech saliva
- Worsening of adductor strain or pubic pain
- Delay of structured rehabilitation and return-to-sport progression
- Failure to identify pubic osteomyelitis if infection workup is incomplete
- Reproductive concerns if leech is placed too close to midline urogenital structures
- Who should not consider this
- Pregnant patients (leech therapy is not done during pregnancy)
- Patients with active urogenital or pelvic infection
- Patients with suspected or confirmed pubic symphysis osteomyelitis
- Patients without imaging confirming the diagnosis (rule out stress fracture, neoplasm)
- Patients on anticoagulants or with anemia
- Patients who have not engaged with structured rehabilitation
- What to ask your clinician
- Has imaging (MRI or bone scan) confirmed the diagnosis and excluded osteomyelitis or stress fracture?
- Have I completed at least 8 to 12 weeks of structured adductor and core rehabilitation?
- Has image-guided corticosteroid injection been considered?
- Where exactly will the leech be placed — confirm it is lateral to midline urogenital structures?
- What is the realistic expected benefit, given that no clinical study of leech therapy for this condition was identified?
- What is the practitioner's experience with this indication?
- When to seek urgent care
- Fever above 38.0 C / 100.4 F, chills, or rigors (rule out osteomyelitis or pelvic infection)
- Sudden severe groin or pubic pain or inability to bear weight
- Visible bleeding from the urethra or vagina
- Spreading redness, warmth, pus, or red streaks at any bite site
- Bleeding from a bite site lasting more than 24 hours
- Difficulty urinating or new urinary symptoms
What this does NOT mean
- It does not substitute for rehabilitation, NSAIDs, or corticosteroid injection.
- It is not appropriate during pregnancy or breastfeeding.
- It does not treat osteomyelitis, which requires culture-directed antibiotics.
- No clinical study of leech therapy for this condition was identified; any benefit beyond placebo or natural-history improvement is unknown.
Safety cross-references
Clinical Profile
- Category
- Musculoskeletal
- ICD-10
- M26.30, M25.88, M85.30
- Safety tier
- Medium
Evidence Summary
Non-pregnancy pubic symphysis dysfunction is most common in athletes (osteitis pubis, adductor enthesopathy). Conventional management includes rest, NSAIDs, and progressive return-to-sport protocols. Pregnancy-related symphysis pubis dysfunction (SPD) is a separate clinical entity and a relative contraindication during the third trimester. No clinical study of leech therapy for pubic symphysis dysfunction or osteitis pubis was identified in PubMed, Europe PMC, Crossref or ClinicalTrials.gov, or in the Baskova and Isakhanyan 2004 monograph; any use is investigational and mechanistic only, and it should not displace evidence-based conservative care.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Active urogenital infection
- Pubic symphysis osteomyelitis
Related Conditions
Sacroiliac Joint Dysfunction
Investigational use for SI joint mechanical pain with positive provocation tests; no clinical study of leech therapy was identified.
Coccydynia (Chronic)
Investigational use for chronic coccyx pain after fall, childbirth, or idiopathic onset; no clinical study of leech therapy was identified.
Chronic Pelvic Pain Syndrome (Non-Specific)
Investigational for non-specific chronic pelvic pain; the only clinical report located is an uncontrolled 60-woman series in which leeches were one part of multimodal care.
Knee Osteoarthritis
Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.